Oral pharmacokinetics of pirenzepine in
โ
T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko
๐
Article
๐
1990
๐
Springer
๐
English
โ 215 KB
The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1